On September 4, 2020 Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, reported that Vu Truong, Ph.D., Chief Executive Officer, will present at the following investor conferences in September (Press release, Aridis Pharmaceuticals, SEP 4, 2020, View Source [SID1234564510]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2020 Cantor Fitzgerald Virtual Global Healthcare Conference on Tuesday, September 15, 2020 at 9:20 AM EDT
H.C. Wainwright 22nd Annual Global Investment Conference on Tuesday, September 15, 2020 at 3:30 PM EDT
A webcast of the Cantor Fitzgerald presentation will be available at View Source A replay of the webcast will be available on the Company’s website for 90 days following the event.